Medical Microinstruments raises $75M for robotic microsurgery

-
Image from Medical Microsintruments

Image from Medical Microsintruments

Robotic microsurgery company Medical Microinstruments announced today that it raised $75 million in a Series B financing round.

Pisa, Italy–based Medical Microinstruments plans to use proceeds from the financing round, along with its planned U.S. presence, to move into its next stage of growth through expanded indications and ongoing commercialization efforts for its Symani microsurgery system.

The company designed Symani to address the challenges of microsurgery with the NanoWrist instruments for accessing and suturing small, delicate anatomy, such as veins, arteries, nerves and lymphatic vessels as small as 0.3mm in diameter. It provides motion scaling and tremor reduction to allow precise micro-movements.

Symani received CE mark in 2019, and the company intends to accelerate commercialization in the U.S. and Asia-Pacific, as well as advance clinical research through an FDA investigational device exemption (IDE) pivotal study.

“This financing round, coupled with our commitment to access the U.S. market and the addition of visionary leaders to our board, is an exciting moment for the surgical robotics space,” Medical Microinstruments CEO Mark Toland said in a news release. “We’re pleased to have bridged the Atlantic with premier U.S. life science investors, and existing European investors, who share our same vision of bringing microsurgical robotics to the world.”

Deerfield Management led the round, while the company received participation from new investors RA Capital Management and Biostar Capital, as well as existing investors Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech.

The company added Deerfield partner Dr. Andrew ElBardissi and RA Capital Management principal Tess Cameron to its board of directors. Additionally, former robotics business development manager for Comau, Arturo Baroncelli, will represent the company’s founders on the board.

Medical Microinstruments also announced a corporate redomicile from Italy to the U.S. Its recently opened Center of Excellence facility in Pisa, with 96 employees, will continue to be the hub of its research and development, manufacturing and other business activities.

“We are thrilled to add further depth and experience to the MMI Board and look forward to working with our new board members to build the robotic microsurgical space,” Andrew Cleeland, chair of the board, said.

The post Medical Microinstruments raises $75M for robotic microsurgery appeared first on The Robot Report.



from The Robot Report - Robotics News, Analysis & Research https://ift.tt/wExoSq3
via artificialconference

Comments

Post a Comment

Popular posts from this blog

Chipotle testing avocado processing robot in test kitchen

-
Image
Chipotle Mexican Grill announced Autocado, an avocado processing cobotic prototype that cuts, cores, and peels avocados before they are hand mashed to create the restaurant’s famous guacamole. The prototype, developed in collaboration with Vebu , is currently being tested at the Chipotle Cultivate Center in Irvine , California.  How Autocado works  A team member loads Autocado with a full case of ripe avocados and selects the size setting. Autocado can hold up to 25 lbs. of avocados at once. One at a time, avocados are vertically oriented, then transferred to the processing device. The avocados are sliced in half. Their cores and skin are automatically removed, and the waste is discarded.  The fruit is safely collected in a stainless-steel bowl at the bottom of the device.  A team member removes the bowl of avocado fruit and moves it to the counter where they add additional ingredients and hand mash the avocados to make Chipotle’s signature guacamole.  How the Autocado idea s
Read more

Inside Comaus testing of Intrinsic Flowstate

-
Image
Intrinsic tested its latest platform and Flowstate with Comau , an Italian-based robot manufacturer and global systems integrator. Comau has been working with Intrinsic for several years now to validate Intrinsic’s platform technology and developer product, Flowstate, through real-world use cases.  Flowstate, announced earlier this year in May , is a robotic software development platform. It’s Intrinsic’s first developer product built on the Intrinsic platform. Comau was also introduced as the company’s first industry partner in May.  The Intrinsic Flowstate software  adds a layer of abstraction to traditional robotic software tools with the goal of reducing the development skillset required while making it easier than ever before to program a robot in simulation. “Partnering with Comau over the years has brought our team a tremendous amount of expertise, knowledge, and real-world use cases to focus our efforts on. We’re excited for what’s next and what it will mean to the solutio
Read more

ABB launches Flexley mobile robots, completing rebranding of ASTI AMRs

-
Image
Rebranded ABB Flexley autonomous mobile robots (AMRs) completes the integration of ASTI into ABB Robotics business. | Credit: ABB ABB launched its first range of rebranded Autonomous Mobile Robots (AMRs) following its acquisition of mobile robot leader ASTI Mobile Robotics in 2021 for $190M . ASTI Mobile Robotics’ solutions are now rebranded and integrated into ABB’s portfolio, grouped under the Flexley name, indicating the flexibility of operations that the AMRs offer. The first rebranded models to be released, Flexley Tug and Flexley Mover, cover applications including towing, trolley transportation up to 5,350 lbs (2000 kg), as well as lifting and transporting racks, containers and pallets of 4,000 lbs (1,500 kg). The ABB Flexley Mover (l) and ABB Flexley Tug (r) become the first rebranded ABB AMRs to be released. | Credit: ABB ABB joins OMRON corporation as the second automation solutions company to offer a complete lineup of autonomous mobile robots (AMRs), industrial robo
Read more